Related Experiment Video
Updated: Feb 1, 2026

Cerenkov Luminescence Imaging CLI for Cancer Therapy Monitoring
Published on: November 13, 2012
Emerging Cellular Therapies for Cancer
Sonia Guedan1,2, Marco Ruella2,3,4, Carl H June2,3,4,5
1Department of Hematology, Hospital Clinic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, Spain;
Abstract:
Genetically engineered T cells are powerful new medicines, offering hope for curative responses in patients with cancer. Chimeric antigen receptor (CAR) T cells were recently approved by the US Food and Drug Administration and are poised to enter the practice of medicine for leukemia and lymphoma, demonstrating that engineered immune cells can serve as a powerful new class of cancer therapeutics. The emergence of synthetic biology approaches for cellular engineering provides a broadly expanded set of tools for programming immune cells for enhanced function. Advances in T cell engineering, genetic editing, the selection of optimal lymphocytes, and cell manufacturing have the potential to broaden T cell-based therapies and foster new applications beyond oncology, in infectious diseases, organ transplantation, and autoimmunity.
Insights
Genetically engineered T cells, including Chimeric Antigen Receptor (CAR) T cells, represent a new frontier in cancer treatment. Advances in synthetic biology and cell engineering promise broader therapeutic applications beyond oncology.
Area of Science:
- Immunology
- Biotechnology
- Oncology
Background:
- Genetically engineered T cells are emerging as potent therapeutics for cancer.
- Chimeric Antigen Receptor (CAR) T cell therapy has gained FDA approval for leukemia and lymphoma.
- Engineered immune cells represent a novel class of cancer treatments.
Purpose of the Study:
- To highlight the potential of genetically engineered T cells in medicine.
- To discuss the role of synthetic biology in enhancing immune cell function.
- To explore future applications of T cell-based therapies.
Main Methods:
- Leveraging synthetic biology for cellular engineering.
- Advancements in T cell engineering techniques.
- Utilizing genetic editing for improved lymphocyte function.
- Optimizing cell manufacturing processes.
Main Results:
- CAR T cells demonstrate efficacy in treating leukemia and lymphoma.
- Synthetic biology expands the toolkit for programming immune cells.
- Engineered T cells offer hope for curative cancer responses.
Conclusions:
- Genetically engineered T cells are a powerful new therapeutic modality.
- Advances in T cell engineering and manufacturing will broaden applications.
- T cell therapies hold promise beyond oncology, including infectious diseases, transplantation, and autoimmunity.
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Emerging Adulthood
Introduction Cardiac Emergencies
Gene Therapy
Applications of GIS: Disaster Management and Emergency Response

